Alzheimer’s drug fails to reduce significant agitation | Psychology and Brain News | Scoop.it
A drug prescribed for Alzheimer's disease does not ease clinically significant agitation in patients, according to a new study conducted by researchers from the U.K., U.S. and Norway.